Lori E. Dodd, PhD

Section Chief, Biostatistician
The National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rockville, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 68 - Tecovirimat for the Treatment of Mpox: A Randomized Placebo-controlled Trial in the Democratic Republic of Congo (PALM007)

  Thursday, October 17, 2024
  10:50 AM – 11:10 AM US PT